RTW Venture Fund Limited Total Voting Rights (6379B)
03 Febbraio 2020 - 08:00AM
UK Regulatory
TIDMRTW
RNS Number : 6379B
RTW Venture Fund Limited
03 February 2020
3 February 2020
RTW VENTURE FUND LIMITED
(the "Company")
TOTAL VOTING RIGHTS
In accordance with DTR 5.6.1R, as at 31 January 2020 the Company
had 169,753,087 Ordinary Shares in issue, each with equal voting
rights, and no shares held in Treasury.
This total voting rights figure can be used by shareholders as
the denominator for the calculations by which they will determine
whether they are required to notify their interest, or a change to
their interest, in the Company under the FCA's Disclosure Guidance
and Transparency Rules.
For further information, please contact:
RTW Investments, LP +1 (646) 343 9280
Stephanie Sirota
Julia Enright
Barclays +44 (0)20 7623 2323
Tom Swerling
Ben Newmark
Ryan McCarthy
J.P. Morgan Cazenove +44 (0)20 7742 4000
William Simmonds
Ed Murray
Oliver Kenyon
James Bouverat (Sales)
Eddie Nissen (Sales)
Brunswick +44 (0)20 7404 5959
Charis Gresser
Simone Selzer
About RTW Venture Fund Limited ("RTW"):
RTW is a listed medical sciences investment company with a focus
on forming, building, and supporting world-class life sciences,
biopharmaceutical and medical technology companies. It intends to
create a diversified portfolio of investments across a range of
businesses, each pursuing the development of superior
pharmacological or medical therapeutic assets to enhance the
quality of life and/or extend patient life.
The Company is externally managed by RTW Investments LP, its
Alternative Investment Fund Manager.
Visit the RTW website at www.rtwfunds.com for more
information.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
TVREAKFFDANEEFA
(END) Dow Jones Newswires
February 03, 2020 02:00 ET (07:00 GMT)
Grafico Azioni Rtw Biotech Opportunities (LSE:RTW)
Storico
Da Feb 2024 a Mar 2024
Grafico Azioni Rtw Biotech Opportunities (LSE:RTW)
Storico
Da Mar 2023 a Mar 2024